<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T03:01:27Z</responseDate>
  <request identifier="oai:figshare.com:article/33937183" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33937183</identifier>
        <datestamp>2026-09-18T17:21:44Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Statistical trend of MTB and rifampicin resistance among study participants.&lt;/p&gt;</dc:title>
          <dc:creator>Solomon Wireko (13946771)</dc:creator>
          <dc:creator>Joseph Nyarko (25073044)</dc:creator>
          <dc:creator>Kristine Harley Arthur-Quayson (25073047)</dc:creator>
          <dc:creator>Osman Abu (25073050)</dc:creator>
          <dc:creator>Rebecca Appiah (25073053)</dc:creator>
          <dc:creator>Mina Ofosu (25073056)</dc:creator>
          <dc:creator>Alexander Kwarteng (173871)</dc:creator>
          <dc:creator>John Gameli Deku (18516150)</dc:creator>
          <dc:creator>Ebenezer Senu (13949151)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>upper east region</dc:subject>
          <dc:subject>provide useful information</dc:subject>
          <dc:subject>77 &amp;# 8211</dc:subject>
          <dc:subject>2019 &amp;# 8211</dc:subject>
          <dc:subject>regional referral facility</dc:subject>
          <dc:subject>referral facilities may</dc:subject>
          <dc:subject>multivariable logistic regression</dc:subject>
          <dc:subject>mycobacterium tuberculosis detection</dc:subject>
          <dc:subject>based surveillance data</dc:subject>
          <dc:subject>02 &amp;# 8211</dc:subject>
          <dc:subject>resistance proportion represents</dc:subject>
          <dc:subject>xlink "&gt; tuberculosis</dc:subject>
          <dc:subject>rif data collected</dc:subject>
          <dc:subject>frequent among rifampicin</dc:subject>
          <dc:subject>regional referral hospital</dc:subject>
          <dc:subject>rifampicin resistance ranged</dc:subject>
          <dc:subject>rifampicin resistance observed</dc:subject>
          <dc:subject>tb programme registers</dc:subject>
          <dc:subject>897 genexpert mtb</dc:subject>
          <dc:subject>2024 &lt;/ p</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>january 2019</dc:subject>
          <dc:subject>referral patterns</dc:subject>
          <dc:subject>programme factors</dc:subject>
          <dc:subject>multivariable analysis</dc:subject>
          <dc:subject>among mtb</dc:subject>
          <dc:subject>rifampicin resistance</dc:subject>
          <dc:subject>drug resistance</dc:subject>
          <dc:subject>rif tests</dc:subject>
          <dc:subject>rif results</dc:subject>
          <dc:subject>mtb detection</dc:subject>
          <dc:subject>high proportion</dc:subject>
          <dc:subject>annual proportion</dc:subject>
          <dc:subject>positive genexpert</dc:subject>
          <dc:subject>genexpert mtb</dc:subject>
          <dc:subject>genexpert laboratory</dc:subject>
          <dc:subject>tb detection</dc:subject>
          <dc:subject>tested cases</dc:subject>
          <dc:subject>temporal patterns</dc:subject>
          <dc:subject>temporal differences</dc:subject>
          <dc:subject>targeted testing</dc:subject>
          <dc:subject>square test</dc:subject>
          <dc:subject>resistant cases</dc:subject>
          <dc:subject>previous treatment</dc:subject>
          <dc:description>&lt;p&gt;Statistical trend of MTB and rifampicin resistance among study participants.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T17:21:38Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0346447.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Statistical_trend_of_MTB_and_rifampicin_resistance_among_study_participants_p_/33937183</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
